Pharmaceutical intermediates
Filgotinib Maleate Intermediates
3 pharmaceutical intermediates for Filgotinib Maleate. Indication: Ulcerative colitis; Rheumatoid arthritis.
About Filgotinib Maleate
- Originator
- Galapagos Nv
- Indication
- Ulcerative colitis; Rheumatoid arthritis
- Approved Date
- 09/24/2020
Available intermediates
3 intermediates currently listed for Filgotinib Maleate. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine | 1010120-55-4 | / | / |
| Thiomorpholine-1,1-dioxide | 39093-93-1 | / | / |
| THIOMORPHOLINE 1,1-DIOXIDE HYDROCHLORIDE | 59801-62-6 | / | / |
Building toward Filgotinib Maleate?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →